NFATc3 Mediates Chronic Hypoxia-induced Pulmonary Arterial Remodeling with α-Actin Up-regulation*

Physiological responses to chronic hypoxia include polycythemia, pulmonary arterial remodeling, and vasoconstriction. Chronic hypoxia causes pulmonary arterial hypertension leading to right ventricular hypertrophy and heart failure. During pulmonary hypertension, pulmonary arteries exhibit increased expression of smooth muscle-α-actin and -myosin heavy chain. NFATc3 (nuclear factor of activated T cells isoform c3), which is aCa2+-dependent transcription factor, has been recently linked to smooth muscle phenotypic maintenance through the regulation of the expression of α-actin. The aim of this study was to determine if: (a) NFATc3 is expressed in murine pulmonary arteries, (b) hypoxia induces NFAT activation, (c) NFATc3 mediates the up-regulation of α-actin during chronic hypoxia, and (d) NFATc3 is involved in chronic hypoxia-induced pulmonary vascular remodeling. NFATc3 transcript and protein were found in pulmonary arteries. NFAT-luciferase reporter mice were exposed to normoxia (630 torr) or hypoxia (380 torr) for 2, 7, or 21 days. Exposure to hypoxia elicited a significant increase in luciferase activity and pulmonary arterial smooth muscle nuclear NFATc3 localization, demonstrating NFAT activation. Hypoxia induced up-regulation of α-actin and was prevented by the calcineurin/NFAT inhibitor, cyclosporin A (25 mg/kg/day s.c.). In addition, NFATc3 knock-out mice did not showed increased α-actin levels and arterial wall thickness after hypoxia. These results strongly suggest that NFATc3 plays a role in the chronic hypoxia-induced vascular changes that underlie pulmonary hypertension.

[1]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[2]  Y. El-Gamal,et al.  Plasma endothelin-1 immunoreactivity in asthmatic children. , 2002, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[3]  X. Bigard,et al.  Cyclosporin A inhibits hypoxia-induced pulmonary hypertension and right ventricle hypertrophy. , 2006, American journal of respiratory and critical care medicine.

[4]  J. Orens,et al.  Dysfunctional voltage-gated K+ channels in pulmonary artery smooth muscle cells of patients with primary pulmonary hypertension. , 1998, Circulation.

[5]  M. Nelson,et al.  NFAT regulation in smooth muscle. , 2003, Trends in cardiovascular medicine.

[6]  A. Nadas,et al.  Rat pulmonary circulation after chronic hypoxia: hemodynamic and structural features. , 1979, The American journal of physiology.

[7]  M. Nelson,et al.  NFAT4 Movement in Native Smooth Muscle , 2001, The Journal of Biological Chemistry.

[8]  S. Sasayama,et al.  Calcineurin-GATA-6 pathway is involved in smooth muscle–specific transcription , 2002, The Journal of cell biology.

[9]  G. Owens,et al.  Regulation of differentiation of vascular smooth muscle cells. , 1995, Physiological reviews.

[10]  W. Seeger,et al.  Activation of Soluble Guanylate Cyclase Reverses Experimental Pulmonary Hypertension and Vascular Remodeling , 2006, Circulation.

[11]  L. Shimoda,et al.  Altered pulmonary vasoreactivity in the chronically hypoxic lung. , 2000, Physiological research.

[12]  J. Molkentin,et al.  Targeted Disruption of NFATc3, but Not NFATc4, Reveals an Intrinsic Defect in Calcineurin-Mediated Cardiac Hypertrophic Growth , 2002, Molecular and Cellular Biology.

[13]  G. Semenza,et al.  Partial HIF-1alpha deficiency impairs pulmonary arterial myocyte electrophysiological responses to hypoxia. , 2001, American journal of physiology. Lung cellular and molecular physiology.

[14]  G. Owens Molecular control of vascular smooth muscle cell differentiation. , 1998, Acta physiologica Scandinavica.

[15]  P. Rabinovitch,et al.  Smooth muscle cell hypertrophy versus hyperplasia in hypertension. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[16]  G. Owens,et al.  Molecular regulation of vascular smooth muscle cell differentiation in development and disease. , 2004, Physiological reviews.

[17]  Paul McLoughlin,et al.  The structural basis of pulmonary hypertension in chronic lung disease: remodelling, rarefaction or angiogenesis? , 2002, Journal of anatomy.

[18]  Y. Ohkawa,et al.  Calcineurin-mediated pathway involved in the differentiated phenotype of smooth muscle cells. , 2003, Biochemical and biophysical research communications.

[19]  S. Earley,et al.  Pressure-induced smooth muscle cell depolarization in pulmonary arteries from control and chronically hypoxic rats does not cause myogenic vasoconstriction. , 2005, Journal of applied physiology.

[20]  Lin Chen,et al.  Transcriptional regulation by calcium, calcineurin, and NFAT. , 2003, Genes & development.

[21]  W. Steudel,et al.  alpha-smooth-muscle actin and microvascular precursor smooth-muscle cells in pulmonary hypertension. , 1999, American journal of respiratory cell and molecular biology.

[22]  K. Stenmark,et al.  Hypoxia induces differentiation of pulmonary artery adventitial fibroblasts into myofibroblasts. , 2004, American journal of physiology. Cell physiology.

[23]  A. Fujimori,et al.  A novel and selective endothelin ET(A) receptor antagonist YM598 prevents the development of chronic hypoxia-induced pulmonary hypertension in rats. , 2005, Vascular pharmacology.

[24]  W. Kummer,et al.  Rapamycin attenuates hypoxia-induced pulmonary vascular remodeling and right ventricular hypertrophy in mice , 2007, Respiratory research.

[25]  G. Crabtree,et al.  Cyclosporin A specifically inhibits function of nuclear proteins involved in T cell activation. , 1989, Science.

[26]  E. Silverman,et al.  Primary pulmonary hypertension in a patient with systemic-onset juvenile arthritis. , 2010, Arthritis and rheumatism.

[27]  I. Fantozzi,et al.  Enhanced expression of transient receptor potential channels in idiopathic pulmonary arterial hypertension. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[28]  K. Morris,et al.  Involvement of RhoA/Rho kinase signaling in pulmonary hypertension of the fawn-hooded rat. , 2006, Journal of applied physiology.

[29]  K. Stenmark,et al.  Mechanisms of structural remodeling in chronic pulmonary hypertension. , 1999, Pediatrics in review.

[30]  B. Walker,et al.  Selective upregulation of arterial endothelial nitric oxide synthase in pulmonary hypertension. , 1997, The American journal of physiology.

[31]  L. Reid,et al.  Ultrastructural features of the distended pulmonary arteries of the normal rat , 1979, The Anatomical record.

[32]  Mark T. Nelson,et al.  Intraluminal Pressure Is a Stimulus for NFATc3 Nuclear Accumulation , 2004, Journal of Biological Chemistry.

[33]  S. M. Sims,et al.  Constrictor-induced translocation of NFAT3 in human and rat pulmonary artery smooth muscle. , 2005, American journal of physiology. Lung cellular and molecular physiology.

[34]  K. Kaibuchi,et al.  Long-Term Treatment With a Rho-Kinase Inhibitor Improves Monocrotaline-Induced Fatal Pulmonary Hypertension in Rats , 2004, Circulation research.

[35]  H. Nakayama,et al.  Calcineurin‐dependent cardiomyopathy is activated by TRPC in the adult mouse heart , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[36]  T. Murphy,et al.  Evidence that Galpha(q)-coupled receptor-induced interleukin-6 mRNA in vascular smooth muscle cells involves the nuclear factor of activated T cells. , 2000, Molecular pharmacology.

[37]  L. Poellinger,et al.  Signal transduction in hypoxic cells: inducible nuclear translocation and recruitment of theCBP/p300 coactivator by the hypoxia‐induciblefactor‐1α , 1998, The EMBO journal.

[38]  M. Arzt,et al.  Effects of ET-A receptor blockade on eNOS gene expression in chronic hypoxic rat lungs. , 2003, Journal of applied physiology.

[39]  G. Semenza,et al.  Hypoxia Inducible Factor 1 Mediates Hypoxia-Induced TRPC Expression and Elevated Intracellular Ca2+ in Pulmonary Arterial Smooth Muscle Cells , 2006, Circulation research.

[40]  M. Nelson,et al.  Constitutively Elevated Nuclear Export Activity Opposes Ca2+-dependent NFATc3 Nuclear Accumulation in Vascular Smooth Muscle , 2003, Journal of Biological Chemistry.

[41]  J. Molkentin,et al.  Novel blocker of NFAT activation inhibits IL-6 production in human myometrial arteries and reduces vascular smooth muscle cell proliferation. , 2007, American journal of physiology. Cell physiology.

[42]  Feng Chen,et al.  Signals Transduced by Ca2+/Calcineurin and NFATc3/c4 Pattern the Developing Vasculature , 2001, Cell.

[43]  P. Leung,et al.  Effects of Chronic Hypoxia on the Circulating and Pancreatic Renin-Angiotensin System , 2002, Pancreas.

[44]  C. Tse,et al.  Chronic Hypoxia–Induced Upregulation of Store-Operated and Receptor-Operated Ca2 Channels in Pulmonary Arterial Smooth Muscle Cells: A Novel Mechanism of Hypoxic Pulmonary Hypertension , 2004, Circulation research.

[45]  L. Chicoine,et al.  Maintained upregulation of pulmonary eNOS gene and protein expression during recovery from chronic hypoxia. , 1999, American journal of physiology. Heart and circulatory physiology.

[46]  R. Priori,et al.  Pulmonary Arterial Hypertension Responsive to Immunosuppressive Therapy in Systemic Lupus Erythematosus , 1993, Lupus.

[47]  B. Walker,et al.  Segmental vasodilatory effectiveness of inhaled NO in lungs from chronically hypoxic rats. , 1998, Respiration physiology.

[48]  S. Archer,et al.  The mechanism of acute hypoxic pulmonary vasoconstriction: the tale of two channels , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[49]  I. Graef,et al.  NFAT signaling in vertebrate development. , 2001, Current opinion in genetics & development.

[50]  M. Juhaszova,et al.  Hypoxia inhibits gene expression of voltage-gated K+ channel alpha subunits in pulmonary artery smooth muscle cells. , 1997, The Journal of clinical investigation.

[51]  M. Yacoub,et al.  Expression of pulmonary vascular angiotensin‐converting enzyme in primary and secondary plexiform pulmonary hypertension , 2000, The Journal of pathology.

[52]  M. Nishida,et al.  Roles of Endothelin ETA and ETB Receptors in the Pathogenesis of Monocrotaline-Induced Pulmonary Hypertension , 2004, Journal of cardiovascular pharmacology.

[53]  L. Hansson The optimal blood pressure reduction , 1996, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[54]  A. Bonev,et al.  Opposing Actions of Inositol 1,4,5-Trisphosphate and Ryanodine Receptors on Nuclear Factor of Activated T-cells Regulation in Smooth Muscle* , 2002, The Journal of Biological Chemistry.

[55]  J. Molkentin,et al.  Activation of NFATc3 Down-regulates the β1 Subunit of Large Conductance, Calcium-activated K+ Channels in Arterial Smooth Muscle and Contributes to Hypertension* , 2007, Journal of Biological Chemistry.

[56]  G. Semenza Perspectives on Oxygen Sensing , 1999, Cell.

[57]  R. Bassel-Duby,et al.  TRPC3 channels confer cellular memory of recent neuromuscular activity. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[58]  R. A. Murphy,et al.  Actin and tropomyosin variants in smooth muscles. Dependence on tissue type. , 1984, The Journal of biological chemistry.

[59]  M. Nelson,et al.  Nuclear Factor of Activated T Cells and Serum Response Factor Cooperatively Regulate the Activity of an α-Actin Intronic Enhancer* , 2005, Journal of Biological Chemistry.

[60]  D. Rodman,et al.  Enhanced ETA-receptor-mediated inhibition of Kv channels in hypoxic hypertensive rat pulmonary artery myocytes. , 1999, American journal of physiology. Heart and circulatory physiology.

[61]  C. Ferri,et al.  Circulating endothelin-1 concentrations in patients with chronic hypoxia. , 1995, Journal of clinical pathology.

[62]  J. Dubois-Randé,et al.  Modulation of angiotensin II receptor expression during development and regression of hypoxic pulmonary hypertension. , 2000, American journal of respiratory cell and molecular biology.

[63]  Y. Fukuchi,et al.  Localization and distribution of endothelin receptor subtypes in pulmonary vasculature of normal and hypoxia-exposed rats. , 1999, American journal of respiratory cell and molecular biology.

[64]  E. Olson,et al.  Angiotensin II-induced stimulation of smooth muscle alpha-actin expression by serum response factor and the homeodomain transcription factor MHox. , 1997, Circulation research.

[65]  K. Morris,et al.  Attenuation of acute hypoxic pulmonary vasoconstriction and hypoxic pulmonary hypertension in mice by inhibition of Rho-kinase. , 2004, American journal of physiology. Lung cellular and molecular physiology.

[66]  N. Morrell,et al.  Angiotensin converting enzyme expression is increased in small pulmonary arteries of rats with hypoxia-induced pulmonary hypertension. , 1995, The Journal of clinical investigation.

[67]  L. Glimcher,et al.  The transcription factor NFAT4 is involved in the generation and survival of T cells. , 1998, Immunity.

[68]  Thomas J. Murphy,et al.  The Cyclosporin A-sensitive Nuclear Factor of Activated T Cells (NFAT) Proteins Are Expressed in Vascular Smooth Muscle Cells , 1998, The Journal of Biological Chemistry.

[69]  P. Hogan,et al.  Transcription factors of the NFAT family: regulation and function. , 1997, Annual review of immunology.